Prognostic Value of Soluble Suppression of Tumorigenicity 2 in Chronic Kidney Disease Patients: A Meta-Analysis

<div>(a) Association between sST2 and total cardiovascular disease (CVD) events in CKD patients. (b) Association between sST2 and heart failure (HF) in CKD patients.</div>

Disease Markers

fig4

Figure 4

Figure 4: Prognostic Value of Soluble Suppression of Tumorigenicity 2 in Chronic Kidney Disease Patients: A Meta-Analysis 